Suppr超能文献

拉米夫定调节唐氏综合征小鼠模型脑组织中神经损伤相关基因和LINE-1逆转座子的表达。

Lamivudine modulates the expression of neurological impairment-related genes and LINE-1 retrotransposons in brain tissues of a Down syndrome mouse model.

作者信息

Borgognone Alessandra, Casadellà Maria, Martínez de Lagrán María, Paredes Roger, Clotet Bonaventura, Dierssen Mara, Elizalde-Torrent Aleix

机构信息

IrsiCaixa, Badalona, Spain.

Center for Genomic Regulation, The Barcelona Institute for Science and Technology, Barcelona, Spain.

出版信息

Front Aging Neurosci. 2024 Jul 19;16:1386944. doi: 10.3389/fnagi.2024.1386944. eCollection 2024.

Abstract

Elevated activity of retrotransposons is increasingly recognized to be implicated in a wide range of neurodegenerative and neurodevelopmental diseases, including Down syndrome (DS), which is the most common chromosomal condition causing intellectual disability globally. Previous research by our group has revealed that treatment with lamivudine, a reverse transcriptase inhibitor, improved neurobehavioral phenotypes and completely rescued hippocampal-dependent recognition memory in a DS mouse model, Ts65Dn. We hypothesized that retrotransposition rates would increase in the Ts65Dn mouse model, and lamivudine could block retrotransposons. We analyzed the differentially expressed long interspersed element-1 (LINE-1 or L1) mapping on MMU16 and 17, and showed for the first time that retrotransposition could be associated with Ts65Dn's pathology, as misregulation of L1 was found in brain tissues associated with trisomy. In the cerebral cortex, 6 out of 26 upregulated L1s in trisomic treated mice were located in the telomeric region of MMU16 near , , and genes. In the hippocampus, one upregulated L1 element in trisomic treated mice was located near the gene on MMU16. Moreover, two downregulated L1s rescued after treatment with lamivudine were located in the intronic region of (MMU17) and (MMU7), implicated in a variety of neurodegenerative disorders. To gain further insight into the mechanism of this improvement, we here analyzed the gene expression profile in the hippocampus and cerebral cortex of trisomic mice treated and no-treated with lamivudine compared to their wild-type littermates. We found that treatment with lamivudine rescued the expression of 24% of trisomic genes in the cortex (located on mouse chromosome (MMU) 16 and 17) and 15% in the hippocampus (located in the human chromosome 21 orthologous regions), with important DS candidate genes such as and , rescued in both regions.

摘要

逆转录转座子活性升高越来越被认为与多种神经退行性疾病和神经发育疾病有关,包括唐氏综合征(DS),这是全球导致智力残疾最常见的染色体疾病。我们团队先前的研究表明,用逆转录酶抑制剂拉米夫定治疗可改善神经行为表型,并完全挽救DS小鼠模型Ts65Dn中依赖海马体的识别记忆。我们推测在Ts65Dn小鼠模型中逆转录转座率会增加,而拉米夫定可以阻断逆转录转座子。我们分析了映射在MMU16和17上差异表达的长散在核元件1(LINE-1或L1),并首次表明逆转录转座可能与Ts65Dn的病理相关,因为在与三体性相关的脑组织中发现了L1的调控异常。在大脑皮层中,三体性处理小鼠中26个上调的L1中有6个位于MMU16的端粒区域附近,靠近 、 和 基因。在海马体中,三体性处理小鼠中一个上调的L1元件位于MMU16上靠近 基因的位置。此外,用拉米夫定治疗后挽救的两个下调的L1位于 (MMU17)和 (MMU7)的内含子区域,这些区域与多种神经退行性疾病有关。为了进一步深入了解这种改善的机制,我们在此分析了与野生型同窝小鼠相比,用拉米夫定处理和未处理的三体性小鼠海马体和大脑皮层中的基因表达谱。我们发现,用拉米夫定治疗可挽救皮层中24%的三体性基因(位于小鼠染色体(MMU)16和17上)和海马体中15% 的三体性基因(位于人类染色体21的同源区域),两个区域中重要的DS候选基因如 和 均得到挽救。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bae/11294114/4480257effb3/fnagi-16-1386944-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验